Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by TriumphSpitSixon Feb 03, 2020 12:31am

119 Views

Post# 30632157

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:FDA IND NEWS!!!!!!!!!!!!!!!!!!

While it's probably based on FDA simply needing more information "to assess the risks to subjects" (Ground 4) since lasers are still somewhat sci-fi technology, I wouldn't be surprised if the clinical hold is based on Ground 5, questions around the potential for "risk of reproductive toxicity."

Not saying there is a risk, but maybe FDA had questions about the potential of laser light to affect women of child-bearing potential and possibly cause sterility? Or is our potential patient pool so much older that this concern is completely out of the question?

Bullboard Posts

Calibre discovers significant gold in Newfoundland